GlassScriptPhysician profile
Brian F Perry
NPI 1235176918
$1,079.05
in general payments reported to CMS, 2019-2025
7 companies · $27.52 in 2025
The $27.52 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $59.37 · 2021: $24.56 · 2022: $25.25 · 2024: $44.23 · 2025: $27.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.23 · Education: $27.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.23 |
| Education | $27.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $787.98 | 2019 | |
| Acclarent, INC | $157.66 | 2019-2022 | |
| Integra Lifesciences Corporation | $44.23 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Takeda Pharmaceuticals U.S.A., INC. | $27.52 | 2025 | Eohilia |
| Baxter Healthcare | $24.56 | 2021 | |
| Stryker Corporation | $20.02 | 2019 | |
| Optinose US, INC. | $17.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.